Gero, a member of the orthopedic medical device company’s board since 1998, was named chairman in 2005. He’ll continue as a consultant to the board until 2015, according to a press release.
Thurman, a private equity consultant, was the founder & CEO of Strategic Reserves LLC and Viasys, according to a regulatory filing, which Cardinal Health acquired for $1.5 billion in 2007.
"On behalf of the board of directors, the Orthofix management team and all employees, I want to thank Jim for his many years of service and tireless commitment to Orthofix," president & CEO Brad Mason said in prepared remarks. "Jim’s leadership and guidance have been integral to Orthofix and its growth, and we wish him the best in his future endeavors."
“I am extremely enthusiastic about joining Orthofix at a time when I believe it is positioned for significant value creation. Brad has assembled an exceptional leadership team, and I am very impressed by the operational improvements that are being implemented at the company. I see this as an inflection point in Orthofix’s future, and I look forward to working with Brad and his team to capitalize on the many opportunities that lie ahead,” Thurman added.
Orthofix said it also added Radius Venture partner Kathleen Regan to the board. No reason was given for Gero’s departure.
Ex-KCI CEO Burzik joins Innovative Trauma Care’s board
Innovative Trauma Care said it added Catherine Burzik, the former CEO of Kinetic Concepts Inc., to its board of directors. Burzik is also a board member of Becton Dickinson & Co. (NYSE:BDX).
Haemonetics global market prez is out at the end of the year
Haemonetics (NYSE:HAE) said global markets president Michael Kelly is slated to depart at the end of the year. Kelly will continue in his current position until Dec. 2 and will help with the transition process until Dec. 31. No replacement has been named at this time.